Convergence Pharmaceuticals Ltd

A return to growth at Biogen, Inc. will not be fast, but new CEO Christopher Viehbacher provided assurances during the company’s fourth quarter earnings call on 1 February that a thorough review of

The Only Way Is A Transaction, Apparently The trials and tribulations associated with Biogen, Inc. ’s anti-amyloid antibody Aduhelm (aducanumab) have taken the product from a potential blockbuster as

The COVID-19 pandemic saw our sector mobilize as never before to tackle the emergency and beat a pathway out of the global health crisis. For 2021, the Scrip Awards were back in person at London’s Roy

Almirall SA has appointed Peter Guenter CEO – effective Oct. 1. Guenter joins the company from Sanofi where he held various senior positions over the past 22 years, most recently as executiv